Literature DB >> 20400104

Microbiota in pediatric inflammatory bowel disease.

Andreas Schwiertz1, Manuela Jacobi, Julia-Stefanie Frick, Markus Richter, Kerstin Rusch, Henrik Köhler.   

Abstract

OBJECTIVE: To test the hypothesis that compared with controls, children with inflammatory bowel disease (IBD) exhibit differences in the relationships between gut microbiota and disease activity. STUDY
DESIGN: Children and adolescents (n = 69; median age, 14 years) with IBD and 25 healthy controls (median age, 14 years) were recruited for the study. The disease activity was determined according to the Pediatric Ulcerative Colitis Activity Index or the Pediatric Crohn Disease Activity Index. Cell counts of 9 bacterial groups and species in the fecal microbiota were monitored by real-time polymerase chain reaction analysis.
RESULTS: Although no major changes were observed in patients with ulcerative colitis, except for a decrease in bifidobacteria in the active state of IBD, children with active and inactive Crohn's disease (CD) had lower numbers of Faecalibacterium prausnitzii and bifidobacteria (P <.05), and patients with active CD had higher numbers of Escherichia coli (P <.05).
CONCLUSIONS: The microbiota in children with CD is characterized by decreased numbers of F praunsitzii and increased numbers of E coli. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400104     DOI: 10.1016/j.jpeds.2010.02.046

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  61 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.

Authors:  Mireia Lopez-Siles; Margarita Martinez-Medina; Carles Abellà; David Busquets; Miriam Sabat-Mir; Sylvia H Duncan; Xavier Aldeguer; Harry J Flint; L Jesús Garcia-Gil
Journal:  Appl Environ Microbiol       Date:  2015-08-21       Impact factor: 4.792

Review 3.  Impact of the gut microbiome on mucosal inflammation.

Authors:  Warren Strober
Journal:  Trends Immunol       Date:  2013-08-16       Impact factor: 16.687

4.  Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.

Authors:  Tanya T Nguyen; Tomasz Kosciolek; Lisa T Eyler; Rob Knight; Dilip V Jeste
Journal:  J Psychiatr Res       Date:  2018-01-31       Impact factor: 4.791

Review 5.  How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients?

Authors:  Lee A Denson
Journal:  Curr Gastroenterol Rep       Date:  2012-06

6.  Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease.

Authors:  Michael J Docktor; Bruce J Paster; Shelly Abramowicz; Jay Ingram; Yaoyu E Wang; Mick Correll; Hongyu Jiang; Sean L Cotton; Alexis S Kokaras; Athos Bousvaros
Journal:  Inflamm Bowel Dis       Date:  2011-10-10       Impact factor: 5.325

Review 7.  Bacterial colonization and intestinal mucosal barrier development.

Authors:  Xiao-Zhong Huang; Li-Bin Zhu; Zhong-Rong Li; Jing Lin
Journal:  World J Clin Pediatr       Date:  2013-11-08

8.  Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.

Authors:  Holger Schäffler; Annika Kaschitzki; Christian Alberts; Peggy Bodammer; Karen Bannert; Thomas Köller; Philipp Warnke; Bernd Kreikemeyer; Georg Lamprecht
Journal:  Int J Colorectal Dis       Date:  2016-03-07       Impact factor: 2.571

9.  Paneth cell defects in Crohn's disease patients promote dysbiosis.

Authors:  Ta-Chiang Liu; Bhaskar Gurram; Megan T Baldridge; Richard Head; Vy Lam; Chengwei Luo; Yumei Cao; Pippa Simpson; Michael Hayward; Mary L Holtz; Pavlos Bousounis; Joshua Noe; Diana Lerner; Jose Cabrera; Vincent Biank; Michael Stephens; Curtis Huttenhower; Dermot Pb McGovern; Ramnik J Xavier; Thaddeus S Stappenbeck; Nita H Salzman
Journal:  JCI Insight       Date:  2016-06-02

Review 10.  The role of the innate and adaptive immune system in pediatric inflammatory bowel disease.

Authors:  Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.